Shield Therapeutics Share Discussion Threads

[peachie 74] 24/3/2020 12:24

Yes. A lot of people will miss out here if they sold.

Deal could be before the summer IMHO. This needs getting to market ASAP, hospital IV will be on the back burner now

75p buys going through as sells. Actually no real dip

[czar] 24/3/2020 12:21

This is one to tuck away for at least 3 years imho, theses shares could and should be a big multiple of today's price. The first step is a US distributor which I expect this Summer, that should see the stock at £3+. And then more and more deals to come. Good luck to holders and commiserations to those that have been flushed out.

[peachie 74] 24/3/2020 11:25

The date of the 26th was only used last year to give notice of results. Which were released 4th April I think

[peachie 74] 24/3/2020 11:10

Highest all share riser atm. About time.

In these times when general health is so important and IV iron supplements require a ( very scarce ) hospital bed, people will be crying out for these tablets.

This was cheap at 150 !
FDA approval BROAD LABEL. US deal to come. Companies must be clambering for this

As will China soon. Over a billion people with higher Fe deficiency rate than Europe /US.

[montyhedge] 24/3/2020 11:04

A actually winner in this market sell off. Yipee, lol

[siriusbizness] 24/3/2020 10:57

Surely we get an trading update Thurs. FCA comms didn’t apply to AIM although most following suit but still issuing an update. Drop is way overdone so expect a big recovery on any update

[montyhedge] 24/3/2020 10:54

Good point, taking orally going to be the new normal. Massive market.

[qs99] 24/3/2020 10:53

Why the sharp rise today?

[montyhedge] 24/3/2020 10:49

If all comes off, must be 240p+

[peachie 74] 24/3/2020 10:44

Must be one of the safest stocks to buy. A derisked proven supplement for the worlds biggest deficiency. All areas are being tanked , but now more than ever the world realises how important health is.

[ny boy] 24/3/2020 10:16

Just holding here, I have plenty, happy that others bought near the lows, where I originally bought, also have more at much higher prices but I don’t need to sell, unless the market proves me wrong.certainly has attracted some fresh bargain hunters too, along with many other stocks. I haven’t added because I have been buying heavily into BP,RR,VOD etc Some of my cash is going into those blue chips for long term recovery.

Let’s hope we get a positive outcome here and news on US commercialization deal


On a minor note..l

Marie1980_M
Member since: 17 Mar 2020

These multiple aliases are getting ridiculous, you have made yourself look a complete imbecile

[peachie 74] 24/3/2020 09:46

And look at this rise on no volume at all.

Imagine how this will rocket when volume starts trading. US deal on its way remember. Could be a real gem in these horrible times.

[peachie 74] 24/3/2020 09:22

About time a little rise. A derisked product for the worlds biggest deficiency.
A multi billion dollar market where hospital beds for Fe infusions will be mega scarce in the current climate.

This is going to look so cheap IMHO in future during the inevitable bounce back

As always DYOR. But the catapult here is being pulled back, when will it be let go ?

[peachie 74] 24/3/2020 07:36

Yes. The numbers he talks for China are eye watering and make a current 66m market cap a drop in the ocean.

[best1467] 23/3/2020 17:41

Peachie Yes seen the interview allso read the in-depth research from Hardman very bullish case made .
It’s a pity that presentation was prior thE H2H news but we should get some clarification soon as to the possible consequences but there is no doubting the potential market and you get the impression that in the long term China could be Massive .

[daveboy1] 23/3/2020 16:07

Looks like probably no results Thursday due to FCA advice. Is that a good or a bad thing I ask myself... deferred maybe for two weeks or perhaps more. I've had notice COG are doing this already. Also gone from Shield site.

[peachie 74] 23/3/2020 08:40

Cheers Best, we will have to agree to disagree, as the H2H did still show it to be non inferior, both in the PP ( more reliable) group at 12 weeks and the longer term results over a year.

Anyway , let’s reassure ourselves with this

hxxps://youtu.be/HAXiqSBrXyE

The recent presentation by CEO. if link doesn’t work just search Shield Therapeutics on YouTube , and it’s the most recent release , presented by Hardman the brokers.

[best1467] 23/3/2020 06:53

Peachie I agree to appoint but it’s a marketing issue they can no longer claim inferiority even though it is none inferior I hope they don’t have to refund a portion of the milestone but it’s uncertainty and as the company as not replied to my question regarding this I suggest it may or may not happen.
But having said all that I have added since the latest drop because on a long term view it’s decent investment feel we do need an further update which I would imagine will come along with the results on the 27th I think GLTAH

[best1467] 22/3/2020 21:39

Just looked back the payment received from Nordgine for the none inferiority H2H study was €2.5 million .

[best1467] 22/3/2020 21:32

If you look back at results they received 1 million Payment due fromNordgine on the back of the H2H study.

[crankyman] 22/3/2020 17:39

Either way it’s still a good basis for a cost effectiveness analysis

[crankyman] 22/3/2020 17:38

Could have been due diligence or the process of publishing it.

[peachie 74] 22/3/2020 16:42

Handy to know the Edison report states this mistake WAS NOT FOUND AS PART OF DUE DILIGENCE IN U.S

Anyway DYOR Good luck

[peachie 74] 22/3/2020 16:38

Where does is state in presentations they received a royalty solely on the back of the ( still successful ) H2H ?